Improved survival in adolescents and young adults (AYA) patients aged 14–55 years with acute lymphoblastic leukemia using pediatric-inspired protocol – a retrospective analysis of a real-world experience in 79 of patients treated at a national tertiary care referral center

[1]  S. Chiaretti,et al.  Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric‐like GIMEMA LAL‐1308 trial , 2020, American journal of hematology.

[2]  T. Zhu,et al.  [A pediatric-inspired regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: results from a single center]. , 2020, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

[3]  L. Muffly,et al.  Pediatric-inspired protocols in adult acute lymphoblastic leukemia: are the results bearing fruit? , 2019, Hematology. American Society of Hematology. Education Program.

[4]  M. Aljurf,et al.  Improved Outcome of a Pediatric-Inspired Protocol for High-Risk Adolescent and Young Adult Acute Lymphoblastic Leukemia Patients Using Peg-Asparaginase and Escalating Dose of Methotrexate: Tolerability and Outcome. , 2019, Clinical lymphoma, myeloma & leukemia.

[5]  C. Bloomfield,et al.  A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403. , 2019, Blood.

[6]  Yun-Jing Huang,et al.  Influence of pre-transplant minimal residual disease on prognosis after Allo-SCT for patients with acute lymphoblastic leukemia: systematic review and meta-analysis , 2018, BMC Cancer.

[7]  A. Bleyer,et al.  Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: A Review , 2018, JAMA oncology.

[8]  Susan M Sawyer,et al.  The age of adolescence. , 2018, The Lancet. Child & adolescent health.

[9]  D. Wechsler,et al.  Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

[10]  Olaf Klungel,et al.  What Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder Interviews. , 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[11]  W. Stock,et al.  How I treat acute lymphoblastic leukemia in older adolescents and young adults. , 2015, Blood.

[12]  B. Leber,et al.  Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia , 2014, Leukemia.

[13]  M. Loh,et al.  T-Lymphoblastic Leukemia (T-ALL) Shows Excellent Outcome, Lack of Significance of the Early Thymic Precursor (ETP) Immunophenotype, and Validation of the Prognostic Value of End-Induction Minimal Residual Disease (MRD) in Children’s Oncology Group (COG) Study AALL0434 , 2014 .

[14]  Mel Greaves,et al.  Acute lymphoblastic leukaemia , 2013, The Lancet.

[15]  C. Pui,et al.  Glucocorticoid use in acute lymphoblastic leukemia: comparison of prednisone and dexamethasone , 2012 .

[16]  D. Hoelzer,et al.  Modern therapy of acute lymphoblastic leukemia. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  C. Pui,et al.  Glucocorticoid use in acute lymphoblastic leukaemia. , 2010, The Lancet. Oncology.

[18]  M. Minden,et al.  Treatment of adults with BCR‐ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen , 2009, British journal of haematology.

[19]  Cheng Cheng,et al.  Treating childhood acute lymphoblastic leukemia without cranial irradiation. , 2009, The New England journal of medicine.

[20]  H. Dombret,et al.  Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  C. Bloomfield,et al.  What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. , 2008, Blood.

[22]  E. Mantadakis,et al.  High‐Dose Methotrexate in Acute Lymphoblastic Leukemia: Where Is the Evidence for Its Continued Use? , 2005, Pharmacotherapy.

[23]  M. Campbell,et al.  High‐dose methotrexate therapy of childhood acute lymphoblastic leukemia: Lack of relation between serum methotrexate concentration and creatinine clearance , 2004, Pediatric blood & cancer.

[24]  J. Cayuela,et al.  Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  J. Neglia,et al.  A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study. , 2002, Blood.